Status:

UNKNOWN

Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis

Lead Sponsor:

Azidus Brasil

Conditions:

Acute Bacterial Conjunctivitis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The primary objective of this study is to evaluate, through clinical parameters, the comparative efficacy between topical Tobracort ® (tobramycin 0.3% dexamethasone + 1% - Chemistry Lab Union) and TOB...

Detailed Description

* Evaluation of signs and symptoms during treatment, with a record of individual scores for each parameter; * Observation and statistical comparison of drug safety, by recording qualitative and quanti...

Eligibility Criteria

Inclusion

  • Patients who agree with all study procedures and sign, by his own free will, IC;
  • Adult patients, regardless of gender, ethnicity or social status, with good mental health;
  • Patients who present at screening visit, a clinical picture of acute bacterial conjunctivitis diagnosed clinically.

Exclusion

  • Patients with clinical diagnosis of conjunctivitis due to any process other than bacterial infection, such as infections by fungi, protozoa, viruses, or allergic conjunctivitis;
  • Patients with a history or clinical diagnosis of other lesions that may affect the outcome, such as glaucoma, corneal ulcer or scars;
  • Patients with known hypersensitivity to any component of the study drug;
  • Concomitant use of ocular medication other than the study;
  • Patients who have made use of systemic anti-inflammatory hormone in the 30 days preceding inclusion;
  • Patients who have made use of systemic antibiotics in the 15 days preceding inclusion;
  • Pregnant or lactating women;
  • Being or having been treated for any type of conjunctivitis is less than 15 days, or have finished treatment at least 7 days

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01227915

Start Date

February 1 2011

Last Update

October 25 2010

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LAL Clínica Pesquisa e Desenvolvimento Ltda

Valinhos, São Paulo, Brazil